Matthew R. Sydes
Rowland Hill St
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 279 publications
Reporting of Cohort and Routinely Collected Data in Randomised Controlled Trial Protocols (SPIRIT-ROUTINE): extension checklist with explanation and elaboration.
Journal: BMJ (Clinical research ed.)
Published: June 12, 2026
Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.
Journal: European urology
Published: May 11, 2026
Tumor proliferation associates with greater sensitivity to androgen receptor pathway inhibition in metastatic prostate cancer.
Journal: The Journal of clinical investigation
Published: March 31, 2026
Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancer.
Journal: The Journal of clinical investigation
Published: March 31, 2026
Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.
Journal: The New England journal of medicine
Published: March 25, 2026
Decentralised clinical trials of investigational medicinal products.
Journal: Drug discovery today
Published: February 23, 2026
Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials.
Journal: JAMIA open
Published: February 12, 2026
Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 06, 2026
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 06, 2026
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials.
Journal: The Lancet. Oncology
Published: November 05, 2025
Last Updated: 09/26/2026